Navigation Links
Cephalon, Inc. to Webcast Analyst Day
Date:10/30/2008

FRAZER, Pa., Oct. 30 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced that its Analyst Day in New York City, to be held on November 5, 2008, will be webcast live on the investor relations section of its website at http://www.cephalon.com.

Cephalon's senior management will review the company's business strategy, marketing plan and research and development initiatives. The presentations will be delivered on Wednesday, November 5, 2008 beginning at approximately 12:30 p.m. EST and ending at 3:15 p.m. EST. The webcast will be archived for one week following the broadcast. To access the webcast, log on to the company's website at http://www.cephalon.com and click on "Investors," then "Webcast." Click on the link and follow the prompts for registration and access.

About Cephalon, Inc.

Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of innovative products in four core therapeutic areas: central nervous system, pain, oncology and addiction. A member of the Fortune 1000, Cephalon currently employs approximately 3,000 people in the United States and Europe. U.S. sites include the company's headquarters in Frazer, Pennsylvania, and offices, laboratories or manufacturing facilities in West Chester, Pennsylvania, Salt Lake City, Utah, and suburban Minneapolis, Minnesota. The company's European headquarters are located in Maisons-Alfort, France.

The company's proprietary products in the United States include: TREANDA(R) (bendamustine hydrochloride) for Injection, AMRIX(R) (cyclobenzaprine hydrochloride extended-release capsules), PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA(R) (fentanyl buccal tablet) [CII], TRISENOX(R) (arsenic trioxide) injection, VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
2. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
3. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
4. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
5. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
6. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
8. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
9. Telik Announces Presentation and Webcast at Bear Stearns Healthcare Conference
10. ZymoGenetics to Webcast Presentation at Two Upcoming Conferences
11. MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Nano Technology Products (ACAMP) hosts, ... /PRNewswire/ - Today ACAMP hosted a health & ... and microfluidics can play a powerful role in ... promote health and improve the quality, cost and ...
(Date:12/4/2009)... (OTC Bulletin Board: BFRE), a company focused on changing the ... non-food cellulosic wastes, has been ranked number 19 on the ... in Bioenergy;" the company,s second consecutive year in the top ... top 20 bioenergy companies for two straight years is a ...
(Date:12/3/2009)... 3 Nikon Corporation, an innovator of advanced ... a licensing agreement with Harvard University granting Nikon ... Microscopy (STORM) technology. Under the terms of the ... and market them with the N-STORM name. ...
(Date:12/3/2009)... VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a ... the treatment of cardiovascular and metabolic disease, today announced ... its Phase 2 FDG-PET clinical trial of VIA-2291. ... carried out at five sites in the US and ...
Breaking Biology Technology:Alberta companies delivering new products to the health & medical marketplace 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4
... - Wisconsin leaves behind an economic year in which ... and the state's tech economy positioned itself to prosper in ... better, but the investment climate must remain warm and state ... would hurt Wisconsin's ability to compete in the global marketplace. ...
... year and outperformed the NASDAQ Composite index , which ... The two key biotech indices, the NASDAQ and the Amex, ... ,The NASDAQ Biotech Index, which holds many more companies' stocks ... and smaller companies), was flat for the year, with no ...
... The United States District Court for the Western District ... against Abbott Laboratories . , ,The Madison-based court affirmed ... based in Gent, Belgium, and rejected Abbott Labs' request for ... labs for infringing on a genotyping patent. Frank Morich, CEO ...
Other Biology Technology:Wisconsin's high-growth economy: '07 predictions 2Wisconsin's high-growth economy: '07 predictions 3Wisconsin's high-growth economy: '07 predictions 42006: A mixed blessing for Midwest life science companies 22006: A mixed blessing for Midwest life science companies 32006: A mixed blessing for Midwest life science companies 42006: A mixed blessing for Midwest life science companies 52006: A mixed blessing for Midwest life science companies 62006: A mixed blessing for Midwest life science companies 72006: A mixed blessing for Midwest life science companies 82006: A mixed blessing for Midwest life science companies 92006: A mixed blessing for Midwest life science companies 102006: A mixed blessing for Midwest life science companies 11
(Date:12/3/2009)... and adapt to changes in our daily environment, as well ... minute junctions where nerve cells communicate, according to a new ... published online this week in the journal Nature . ... professor of physiology and neuroscience at NYU School of Medicine, ...
(Date:12/3/2009)... on windows or solar panels that repels grime and ... car? New Tel Aviv University research, just published in ... peptides at the nano-scale level that could make these ... , Operating in the range of 100 nanometers (roughly ...
(Date:12/3/2009)... Now in its 32nd year, the CTRC-AACR San Antonio ... breast cancer science and world leaders from industry and ... , This year, more than 8,500 scientists and other ... Center in San Antonio from Dec. 9-13, 2009. The ...
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2A window that washes itself? 2CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Neurocrine Biosciences Secures Committed Equity Financing Facility 14065 1Neurocrine Biosciences Secures Committed Equity Financing Facility 14065 2Neurocrine Biosciences Secures Committed Equity Financing Facility 14065 3Celiac Disease May Raise Risk of Dying 57272 1FDA Approves 4 Swine Flu Vaccines 57268 1FDA Approves 4 Swine Flu Vaccines 57268 2FDA Approves 4 Swine Flu Vaccines 57268 3FDA Approves 4 Swine Flu Vaccines 57268 4
... NEW YORK (Jan. 29, 2008) -- The Prostate Cancer ... has given $5 million to four institutions, including Weill ... cancer. The gift is one of the largest-ever individual ... team, created by the Prostate Cancer Foundation, will seek ...
... of Lake Victoria and of the people living along ... new study suggests that the dams systematic overuse of water ... between 2000 and 2006 and that this drop was ... Tanzania National Parks and Eric Wolanski of James Cook University ...
... spores were mailed to several news media offices and ... others. Clearing the Senate office building of the spores ... the Government Accountability Office. Cleaning the Brentwood postal facility ... , Researchers at the Georgia Tech Research Institute ...
Other Biology News:Nanomedicine research for prostate cancer supported by $5 million gift 2Nanomedicine research for prostate cancer supported by $5 million gift 3New threat to Lake Victoria? 2New decontamination system kills anthrax rapidly without lingering effects 2New decontamination system kills anthrax rapidly without lingering effects 3New decontamination system kills anthrax rapidly without lingering effects 4
... have been developed for affinity capture ... variety of ProteinChip chemical surfaces allow ... their unique biochemical properties. Each chip ... sample comparison, and the chips are ...
... kit, 100 preps Storage: The kit is stable ... storage, keep all contents of the kit cold. ... kit utilizes a silica-gel based membrane which selectively ... the presence of specialized binding buffers. Nucleotides, oligos ...
The Sony UPD895 printer is used to print data captured with the Gel Doc XR and ChemiDoc XRS gel documentation systems as well as the VersaDoc imaging systems....
... FLISP Assay with SR-101 Labeled Substrates ... • Accurately measure serine protease activation ... • B-Bridge's FLISP Kits utilize cell-permeable, ... (FLISPs) to measure chymotrypsin-like activity in ...
Biology Products: